{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:02:32Z","timestamp":1774123352781,"version":"3.50.1"},"reference-count":47,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2009,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Backgrounds\/Aims: <\/jats:bold> It has been reported that tamoxifen may affect hepatoma cell growth <jats:italic>in vitro<\/jats:italic> by suppressing transforming growth factor \u03b2\u20101 (TGF\u2010\u03b21) expression, suggesting that tamoxifen might also retard fibrogenesis. Thus, we examined whether tamoxifen might suppress TGF\u2010\u03b21 expression and consequently inhibit the process of hepatic fibrosis <jats:italic>in vivo<\/jats:italic>.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> To induce periportal hepatic fibrosis, 50 male adult Sprague\u2013Dawley rats were injected with 0.62\u2003mmol\/kg of allyl alcohol, intraperitoneally, twice a week for 8 weeks. Hepatic fibrosis scores, intrahepatic collagen levels and plasma TGF\u2010\u03b21 expression levels were evaluated in three groups of 10 rats orally administered tamoxifen at 1, 5 and 10\u2003mg\/kg, respectively, and in 20 controls. Messenger RNAs (mRNAs) encoding TGF\u2010\u03b21 and TGF\u2010\u03b2 receptors in liver tissue were semiquantified using reverse transcriptase polymerase chain reaction.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> Hepatic fibrosis scores decreased progressively as the dose of tamoxifen increased, resulting in a significant change in rats treated with tamoxifen at 10\u2003mg\/kg compared with controls (<jats:italic>P<\/jats:italic>=0.018). Intrahepatic collagen content was significantly less in the group treated with tamoxifen at 10\u2003mg\/kg compared with the control (<jats:italic>P<\/jats:italic>=0.045). Plasma TGF\u2010\u03b21 levels were also significantly lower in rats treated with tamoxifen at 10\u2003mg\/kg compared with controls (<jats:italic>P<\/jats:italic>=0.007). All three concentrations of tamoxifen tested decreased the expression levels of hepatic TGF\u2010\u03b21 mRNA and type I TGF\u2010\u03b2 receptor (TGF\u2010\u03b2 RI) mRNA to similar extents.<\/jats:p><jats:p><jats:bold>Conclusions: <\/jats:bold> Tamoxifen seems to inhibit the process of hepatic fibrosis dose\u2010dependently by suppressing the transcription of TGF\u2010\u03b21 and TGF\u2010\u03b2 RI in an experimental model of periportal hepatic fibrosis.<\/jats:p>","DOI":"10.1111\/j.1478-3231.2008.01811.x","type":"journal-article","created":{"date-parts":[[2010,3,30]],"date-time":"2010-03-30T04:56:42Z","timestamp":1269925002000},"page":"308-314","source":"Crossref","is-referenced-by-count":12,"title":["Antifibrogenic effects of tamoxifen in a rat model of periportal hepatic fibrosis"],"prefix":"10.1111","volume":"29","author":[{"given":"Soo Hyung","family":"Ryu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young\u2010Hwa","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Kyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong A.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Woo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myoung Kuk","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neung Hwa","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han Chu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung Sang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Jin","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,1,6]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"56","article-title":"Experimental models of hepatic fibrosis","volume":"10","author":"Takamoto H","year":"1990","journal-title":"a review"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1700420104"},{"key":"e_1_2_6_4_2","first-page":"273","article-title":"Factors influencing collagen content in experimental cirrhosis","volume":"25","author":"Morrione TG.","year":"1949","journal-title":"Am J Pathol"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655200750023057"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2000.170"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(90)91028-5"},{"key":"e_1_2_6_8_2","first-page":"1323","article-title":"Cytokine modulation of intestinal epithelial cell restitution","volume":"105","author":"Dignass AU","year":"1993","journal-title":"central role of transforming growth factor-\u03b21"},{"key":"e_1_2_6_9_2","first-page":"145","article-title":"TGF\u2010\u03b2 (transforming growth factor\u2010\u03b2) in chronic inflammatory conditions \u2013 a new diagnostic and prognostic marker?","volume":"8","author":"Marek A","year":"2002","journal-title":"Med Sci Monit"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005043421807"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411103311907"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510270416"},{"key":"e_1_2_6_13_2","first-page":"10","article-title":"The effects of tamoxifen on human hepatocellular carcinoma cell proliferation and transforming growth factor\u2010beta 1 expression","volume":"9","author":"Shin JW","year":"2003","journal-title":"Korean J Hepatol"},{"key":"e_1_2_6_14_2","first-page":"1409","article-title":"Chronic hepatitis","volume":"19","author":"Batt KP","year":"1995","journal-title":"an update on terminology and reporting"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v113.pm9352873"},{"key":"e_1_2_6_16_2","first-page":"815","article-title":"Measurement of fibrosis in needle liver biopsies","volume":"5","author":"Jimenez W","year":"1985","journal-title":"evaluation of a colorimetric method"},{"key":"e_1_2_6_17_2","first-page":"506","volume-title":"Hepatology: A Textbook of Liver Disease","author":"Bissell DM","year":"1996"},{"key":"e_1_2_6_18_2","first-page":"377","article-title":"Lack of effect of colchicine in alcoholic cirrhosis","volume":"14","author":"Cortez\u2010Pinto H","year":"2002","journal-title":"final results of a double blind randomized trial"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0676.2001.021002129.x"},{"key":"e_1_2_6_20_2","first-page":"161","article-title":"The effect of d\u2010penicillamine on experimental liver cirrhosis induced by CCl4","volume":"30","author":"Schaff Z","year":"1990","journal-title":"Morphol Igazsagugyi Orv Sz"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.2741\/okuno"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70019-3"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.18658"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02208605"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655902320783953"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-200208000-00038"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.73.864.653"},{"key":"e_1_2_6_28_2","first-page":"239","article-title":"Riedel's thyroiditis treated with tamoxifen","volume":"4","author":"Dabelic N","year":"2003","journal-title":"Croat Med J"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/003693300104600211"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjps.1997.0100"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000637-199805000-00008"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1006\/jsre.2001.6350"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/archfaci.3.2.111"},{"key":"e_1_2_6_34_2","first-page":"593","article-title":"Tamoxifen induced hepatotoxicity in breast cancer patients with pre\u2010existing liver steatosis","volume":"16","author":"Elefsiniotis IS","year":"2004","journal-title":"the role of glucose intolerance"},{"key":"e_1_2_6_35_2","first-page":"S87","article-title":"Review of the toxicology of tamoxifen","volume":"24","author":"Wogan GN.","year":"1997","journal-title":"Semin Oncol"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.45.120403.100058"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)61117-0"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.2741\/A812"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.1999.0660"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200323761"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1532-0456(02)00249-1"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.24832"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02445092"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(88)90132-4"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.13.15.2105"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-17554"},{"key":"e_1_2_6_47_2","first-page":"1730","article-title":"Role of transforming growth factor beta type II receptor in hepatic fibrosis","volume":"29","author":"Roulot D","year":"1999","journal-title":"studies of human chronic hepatitis C and experimental fibrosis in rats"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20225"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2008.01811.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2008.01811.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T02:27:52Z","timestamp":1697250472000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2008.01811.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,6]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10.1111\/j.1478-3231.2008.01811.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2008.01811.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,6]]}}}